EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile

Wei Chen, Lin Xu, Long Wang, Yu-Nan Shan, Yan Li, Jin-Shui Zhu

Frontiers in Cellular and Infection Microbiology · 02.04.2025 · 15

DOI: 10.3389/fcimb.2025.1541289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.04.2025. Verfasst von Wei Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Signal Transduction, Colitis, Ulcerative. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinically, Qing-Re-Hua-Shi Decoction (QRHSD) has been clinically used to treat ulcerative colitis (UC) with satisfactory outcomes and minimal side effects. However, its molecular mechanisms remain unclear.

Purpose

This study investigates the effects of QRHSD on DSS-induced colitis in mice, employing multi-omics analyses, including RNA-seq transcriptomics, 16S rRNA microbiomics, non-targeted metabolomics, and network pharmacology analysis.

Methods

The chemical composition of QRHSD was analyzed using quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS). A UC mice model was induced by 3% DSS for 7 days. The effects and mechanisms of QRHSD on UC were evaluated via hematoxylin and eosin, immunofluorescence assay, flow cytometry, western blot, RNA-seq transcriptomics, 16S rRNA microbiomics, non-targeted metabolomics, and network pharmacology. Correlation analyses and validation experiments explored links between transcriptomic, microbiome, metabolomic profiles, and UC-related clinical indices.

Results

UPLC-Q-TOF/MS identified 55 compounds in QRHSD. QRHSD significantly reduced clinical activity, histological changes, and inflammatory factors in UC mice, regulated Th17/Treg balance, and enhanced intestinal barrier integrity. 16S rRNA analysis showed that QRHSD altered gut microbiota composition, increasing beneficial bacteria (e.g., Lactobacillus ) and decreasing harmful bacteria (e.g., Morganella ). Non-targeted metabolomics revealed 507 metabolites associated with UC amelioration, enriched in pathways like bile secretion, ABC transporters, and amino acid biosynthesis. RNA-seq analysis, network pharmacology, and experimental verification showed that QRHSD significantly regulated key signaling pathways, including PI3K/AKT, NF-κB, and MAPK signaling pathways. Finally, correlation analysis highlighted connections among UC-related clinical factors, gut microbiota, and metabolites.

Conclusion

QRHSD could modulate the gut microbiota, metabolic homeostasis, and multiple signal pathways in the treatment of DSS-induced UC, revealing the mechanism of traditional Chinese medicine therapy for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrugs, Chinese HerbalSignal TransductionColitis, UlcerativeColitisMetabolomeAnimalsMiceDisease Models, AnimalDextran SulfateMetabolomicsRNA, Ribosomal, 16SMice, Inbred C57BLMale

Stichwörter der Autor:innen

Qing-Re-Hua-Shi Decoctiongut microbiotametabolic homeostasismulti-omics analysismultiple signal pathwaysulcerative colitis

Substanzen

Drugs, Chinese HerbalDextran SulfateRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.

Zitieren

APA

Chen, W., Xu, L., Wang, L., Shan, Y. N., Li, Y., & Zhu, J. S. (2025). Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1541289

Vancouver

Chen W, Xu L, Wang L, Shan YN, Li Y, Zhu JS. Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1541289

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Xu, Lin and Wang, Long and Shan, Yu-Nan and Li, Yan and Zhu, Jin-Shui},
  title = {Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1541289}
}
Kostenlos starten →